Teleman Dan Benjamin
SEC insider (Form 3/4/5 filer). CIK 0002122500. Chief Executive Officer at Nasus Pharma Ltd (NSRX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in TEL-AVIV-YAFO.
Companies Teleman Dan Benjamin has filed insider reports for
- Nasus Pharma Ltd (NSRX): Director, Officer, Chief Executive Officer
Teleman Dan Benjamin
CIK: 0002122500
Transaction Breakdown
Open Market Buys (P)3 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NSRX
Nasus Pharma Ltd
DirectorOfficer